Ofslager
Christian Ofslager, Newburgh, NY US
Patent application number | Description | Published |
---|---|---|
20100249169 | FORMULATIONS FOR PARENTERAL DELIVERY OF COMPOUNDS AND USES THEREOF - The present invention provides formulations that achieve effective delivery of methylnaltrexone compositions. The provided formulations are useful for preventing, treating delaying, diminishing or reducing the severity of side effects resulting from use of analgesic opioids. | 09-30-2010 |
20120059025 | DRY POWDER COMPOUND FORMULATIONS AND USES THEREOF - The present invention provides lyophilized formulations comprising methylnaltrexone, and processes for preparation of provided formulations. Additionally provided are compositions and products containing the methylnaltrexone formulation, as well as methods for producing formulations, compositions and products. Provided formulations as well as compositions and products containing methylnaltrexone formulations are useful for preventing, treating delaying, diminishing or reducing the severity and/or incidence of side effects resulting from administration of analgesic opioids. | 03-08-2012 |
20150025100 | FORMULATIONS FOR PARENTERAL DELIVERY OF COMPOUNDS AND USES THEREOF - The present invention provides formulations that achieve effective delivery of methylnaltrexone compositions. The provided formulations are useful for preventing, treating delaying, diminishing or reducing the severity of side effects resulting from use of analgesic opioids. | 01-22-2015 |
Christian Luther Ofslager, Newburg, NY US
Patent application number | Description | Published |
---|---|---|
20100035845 | TIGECYCLINE FORMULATIONS - The invention is directed to a frozen pharmaceutical formulation suitable for administration to a subject parenterally, comprising a therapeutically effective amount of tigecycline and an agent selected from the group consisting of lactose, dextrose, glucose, mannose, sucrose, ribose, xylose and a combination thereof, wherein the formulation in a pre-frozen state at about 22° C. or in an unfrozen state at about 22° C. has a pH in the range of from 4.0 to 5.5. Preferably, the formulation is suitable for storage at or below about −20° C. over a period of at least about 2 months, preferably 6 months, more preferably 26 months. Alternatively, the formulation is suitable for storage at about 22° C. over a period of about 24 hours. | 02-11-2010 |
Christian Luther Ofslager, Newburgh, NY US
Patent application number | Description | Published |
---|---|---|
20090176720 | COMPOSITIONS CONTAINING PIPERACILLIN AND TAZOBACTAM USEFUL FOR INJECTION - An aminocarboxylic acid chelating agent, preferably EDTA, or a salt thereof has been found to be useful for inhibiting particulate formation in piperacillin/tazobactam parenteral combinations. The composition may also contain a buffer, preferably citrate, and optionally an aminoglycoside. The product may be in the form of a frozen composition that can be thawed for use. The product may also be in the form of a cryodesiccated powder that can be reconstituted by addition of an aqueous vehicle to reform a solution. | 07-09-2009 |
20110166091 | Compositions Containing Piperacillin and Tazobactam Useful for Injection - An aminocarboxylic acid chelating agent, preferably EDTA, or a salt thereof has been found to be useful for inhibiting particulate formation in piperacillin/tazobactam parenteral combinations. The composition may also contain a buffer, preferably citrate, and optionally an aminoglycoside. The product may be in the form of a frozen composition that can be thawed for use. The product may also be in the form of a cryodesiccated powder that can be reconstituted by addition of an aqueous vehicle to reform a solution. | 07-07-2011 |
20120277197 | TIGECYCLINE FORMULATIONS - The invention is directed to a frozen pharmaceutical formulation suitable for administration to a subject parenterally, comprising a therapeutically effective amount of tigecycline and an agent selected from the group consisting of lactose, dextrose, glucose, mannose, sucrose, ribose, xylose and a combination thereof, wherein the formulation in a pre-frozen state at about 22° C. or in an unfrozen state at about 22° C. has a pH in the range of from 4.0 to 5.5. Preferably, the formulation is suitable for storage at or below about −20° C. over a period of at least about 2 months, preferably 6 months, more preferably 26 months. Alternatively, the formulation is suitable for storage at about 22° C. over a period of about 24 hours. | 11-01-2012 |
Scott Ofslager, Albion, NY US
Patent application number | Description | Published |
---|---|---|
20090188099 | PRE-NESTING OF THE ACTIVE AREA ON PLATES TO REDUCE THICKNESS VARIATION - A method for preparing a bipolar plate assembly for a fuel cell stack is provided. The method first includes the steps of providing a first unipolar plate having a first active area with a plurality of channels formed on a first inner surface thereof, and a second unipolar plate having a second active area with a plurality of lands formed on a second inner surface thereof. The first unipolar plate and the second unipolar plate are aligned to dispose the first active area adjacent the second active area. A first pressure is then applied to the first and second active areas to pre-nest the first active area and the second active area. The perimeters of the first and second unipolar plates are then joined. A clamping fixture and associated method for assembling the bipolar plate assembly is also provided. | 07-30-2009 |
Scott C. Ofslager, Albion, NY US
Patent application number | Description | Published |
---|---|---|
20090197147 | METAL BEAD SEAL FOR FUEL CELL PLATE - A bead seal structure is disclosed for sealing between plates of a fuel cell system, wherein the bead seal structure militates against a leakage of fluids from the fuel cell system and a cost thereof is minimized. | 08-06-2009 |
20130192380 | PRESSURE SENSING ASSEMBLY AND METHOD FOR AN INFUSION PUMP - A pressure sensing assembly for an infusion pump, including: a tubing guide arranged to receive tubing; a displaceable load assembly at least partially disposed within the tubing guide and with a first surface facing in a first direction; a load cell facing the load assembly in the first direction; and a displacement assembly engaged with the tubing guide, facing the first surface in a second direction, opposite the first direction, and exerting a first force on the load assembly in the first direction. The load cell is arranged to detect a second force, greater than the first force, acting on the load cell in the second direction. | 08-01-2013 |